Pharmaco - Press Releases

Date	Title	Company
31-Jul-2020	Hoth Therapeutics Executes Licensing Agreement of VNLG-152 for Treatment of Dermatological Diseases	Hoth Therapeutics, Inc.
31-Jul-2020	Corona-related precautious free capacities reserved as a precaution in the second quarter of 2020 led to a decline in sales and earnings in the Group - a reliable forecast for the 2020 financial year is not yet possible	MediClin AG
31-Jul-2020	NICE Recommends BAVENCIO® (Avelumab) in Combination with Axitinib for First-Line Treatment of Adult Patients with Advanced Renal Cell Carcinoma	Merck
31-Jul-2020	Takeda Pharmaceutical Company Limited: Notice of the Revised Forecast of Consolidated Financials for FY2020 (IFRS)	Takeda Pharmaceutical Company Limited
31-Jul-2020	Harbour BioMed Announces Strategic Partnership with Viva Biotech to Collaborate on Incubating Innovative Biotech Start-ups	Harbour BioMed
30-Jul-2020	Invitation to MorphoSys' Second Quarter and First Half 2020 Results Conference Call on August 6, 2020	MorphoSys AG
30-Jul-2020	New study co-authored by InsightRX shows model-informed precision dosing could improve efficacy of hematopoietic cell transplants while reducing toxicity	InsightRX
30-Jul-2020	Announcing a New Quick Group Podcast Focused on the Needs of the Pharma, Biotech and Life Science Industries, "Logistics: A Matter of Technology, Temperature & Time"	The Quick Group
30-Jul-2020	Eckert & Ziegler: Implementation of the share split by issuing bonus shares to be effective on 4 August 2020	Eckert & Ziegler Strahlen- und Medizintechnik AG
30-Jul-2020	JanOne bolsters its scientific advisory board with two leaders in the medical field for vascular regeneration and interventional pain	JanOne
30-Jul-2020	Single Dose of Johnson & Johnson COVID-19 Vaccine Candidate Demonstrates Robust Protection in Pre-clinical Studies	Johnson & Johnson
30-Jul-2020	Fresenius Medical Care AG & Co. KGaA: Fresenius Medical Care delivers very strong second quarter results	Fresenius Medical Care AG & Co. KGaA
30-Jul-2020	Pharming Group reports financial results for the first half of 2020	Pharming Group N.V.
30-Jul-2020	Henlius and Accord Healthcare Receive EMA Approval for Zercepac®, trastuzumab biosimilar	Henlius
29-Jul-2020	Viking Therapeutics Reports Second Quarter 2020 Financial Results and Provides Corporate Update	Viking Therapeutics, Inc.
29-Jul-2020	Arena Pharmaceuticals to Release Second Quarter 2020 Financial Results and Provide Corporate Update on August 5	Arena Pharmaceuticals, Inc.
29-Jul-2020	A Strong Signal in Turbulent Times: Vetter Achieves Carbon Dioxide-Neutral Levels	B3C newswire
29-Jul-2020	Product Launch: CytoSMART Technologies Announces Automated Organoid Counter	CytoSMART Technologies
29-Jul-2020	Intravacc and Celonic to Develop and Produce a Novel COVID-19 Vaccine	B3C newswire
29-Jul-2020	Cadila Pharmaceuticals expands oncology portfolio with biosimilar cancer drug Bevaro™	CADILA PHARMACEUTICALS LTD